Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes

Luca Liberale, Fabrizio Montecucco, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Marina Padroni, Franco Dallegri, François Mach, Enrico Fainardi, Federico Carbone

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Soluble mediators have been investigated to predict the prognosis of acute ischaemic stroke (AIS). Among them, proprotein convertase subtilisin/kexin type 9 (PCSK9) might have both clinical and pathophysiological relevance. Materials and methods: All available serum samples from a cohort of patients with first AIS (n = 72) were tested for PCSK9 and included in this substudy analysis. The primary endpoint investigated the predictive value of early PCSK9 level variations (ΔPCSK9) from AIS onset to day 7 or from day 1 to day 7, towards a 90-day outcome by modified Rankin Scale (mRS). The secondary endpoint explored the association between ΔPCSK9 and the risk of major adverse cardiovascular events (MACEs). Results: Decreased serum PCSK9 levels at days 1 and 7 were associated with poor clinical outcomes at day 90. At the cut-off point identified by ROC curve analysis (−61·28 ng/mL), ΔPCSK9 day 7–day 1 predicted a poor mRS at day 90 after AIS. ΔPCSK9 day 7–day 1 ≤ −61·28 ng/mL was associated with an increased rate of MACEs. Conclusion: A decrease in PCSK9 levels was a predictor for poor outcome and increased MACEs after AIS. Additional studies targeting post-AIS PCSK9 levels and activity are required to clarify the prognostic and pathophysiological relevance of PCSK9 after AIS.

Original languageEnglish
Pages (from-to)1053-1062
Number of pages10
JournalEuropean Journal of Clinical Investigation
Volume46
Issue number12
DOIs
Publication statusPublished - Dec 1 2016

Keywords

  • Cholesterol
  • injury
  • ischaemic stroke
  • PCSK9

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes'. Together they form a unique fingerprint.

Cite this